ArticlePeerJ2020

Acarbose-metformin is more effective in glycemic variability control than repaglinide-metformin in T2DM patients inadequately controlled with metformin: a retrospective cohort study.

Guoli Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.